Skip to Content


UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Dermatological agent


Antipruritic agent

Chemical Name

(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(E)-2-[(1R,3R,4S)-4-Chloro-metoxycyclohexyl]-1-metylvinyl]-8-etyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimetoxy-4,10,12,18-tetrametyl-15,19-epoxy-3H-pyrido[2,1 (WHO)

Foreign Names

  • Pimecrolimusum (Latin)
  • Pimecrolimus (German)
  • Pimecrolimus (French)
  • Pimecrolimus (Spanish)

Generic Names

  • Pimecrolimus (OS: USAN, BAN, JAN)
  • 33-Epi-chloro-33-desoxyascomycin (IS)
  • ASM 981 (IS)
  • Elidel (IS)
  • SDZ ASM 981 (IS)

Brand Names

  • Aregen
    Meda Pharm, Greece
  • Elidel
    A. Menarini, Singapore; Combiphar, Indonesia; Meda, Bosnia & Herzegowina; Meda, Belgium; Meda, Denmark; Meda, Estonia; Meda, Finland; Meda, Hungary; Meda, Iceland; Meda, Italy; Meda, Latvia; Meda, Malta; Meda, Netherlands; Meda, Norway; Meda, Poland; Meda, Romania; Meda, Sweden; Meda, Turkey; Meda Pharm, Austria; Meda Pharm, Greece; Meda Pharma, Czech Republic; Meda Pharma, Thailand; Meda Pharma Sau, Spain; Meda Pharmaceuticals, United Kingdom; Meda Pharmaceuticals Pty Ltd, Australia; Medcor, Netherlands; Medical Intertrade, Croatia (Hrvatska); Novartis, Argentina; Novartis, Bangladesh; Novartis, Brazil; Novartis, Chile; Novartis, China; Novartis, Ecuador; Novartis, Israel; Novartis, Lebanon; Novartis, Oman; Novartis, Serbia; Novartis, Taiwan; Novartis, Venezuela; Novartis AH, South Africa; Novartis Healthcare, Philippines; SIA Meda Pharma, Lithuania; Valeant, United States; Valeant Pharmaceuticals International, Canada; Viatris, Portugal
  • Elidel 1%
    MEDA Pharma, Switzerland; Meda Pharmaceuticals, Cyprus; Novartis, Egypt; Novartis, New Zealand
  • Rizan
    Meda Pharma Sau, Spain


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.